
A physician-scientist spent years turning the overlooked thymus into an engineering problem. His path from Akron to Cambridge, the NIH and Harvard ended in a deal - but the longer experiment is only beginning.
Most of biotech chases the diseases you can see. Thymmune went after the organ almost no one thinks about - the thymus - and built a way to grow it from stem cells.